Literature DB >> 18936353

Correlation of plasma 25-hydroxyvitamin D levels with severity of primary hyperparathyroidism and likelihood of parathyroid adenoma localization on sestamibi scan.

Emad Kandil1, Anthony P Tufaro, Kathryn A Carson, Frank Lin, Helina Somervell, Tarik Farrag, Alan Dackiw, Martha Zeiger, Ralph P Tufano.   

Abstract

OBJECTIVES: To determine the relationship between preoperative plasma 25-hydroxyvitamin D (25[OH]D) levels and severity of primary hyperparathyroidism (PHPT) and to explore whether presurgical 25(OH)D levels could predict the likelihood of positive results on technetium Tc 99m sestamibi scintigraphy.
DESIGN: Retrospective analysis.
SETTING: Tertiary university referral center. PATIENTS: A total of 421 consecutive patients underwent preoperative sestamibi scintigraphy and parathyroid exploration. Patients with cholecalciferol (vitamin D) deficiency, defined as plasma levels lower than 25 ng/mL, were compared with patients having no vitamin D deficiency. We explored the relationship between 25 (OH)D levels and intact parathyroid hormone (iPTH) levels, alkaline phosphatase (ALKP) levels, adenoma weight, binary sestamibi scan results, and postoperative serum calcium levels (at 1 week and 6 months). MAIN OUTCOME MEASURES: We hypothesized that severity of hypovitaminosis D would correlate with severity of PHPT and predict the likelihood of a positive finding on sestamibi scan.
RESULTS: Concentrations of iPTH and ALKP and parathyroid adenoma weight were significantly higher in patients with lower 25(OH)D levels (P < .01 for all). Patients with hypovitaminosis D had a greater percentage decrease in serum calcium levels 1 week and 6 months postoperatively (P < .05). Median 25(OH)D levels were lower in patients with positive sestamibi scan results (P < .001).
CONCLUSIONS: Patients with hypovitaminosis D present with more advanced indices of PHPT. Parathyroid sestamibi scanning is more likely to show positive results for this subset of patients who may then benefit from sestamibi scan-directed surgical intervention.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18936353     DOI: 10.1001/archotol.134.10.1071

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  9 in total

1.  Pre-operative localization of abnormal parathyroid tissue by 99mTc-sestamibi in primary hyperparathyroidism using four-quadrant site analysis: an evaluation of the predictive value of vitamin D deficiency.

Authors:  Yu-Kwang Donovan Tay; Randy Yeh; Jennifer H Kuo; Catherine McManus; James A Lee; John P Bilezikian
Journal:  Endocrine       Date:  2018-02-05       Impact factor: 3.633

Review 2.  Imaging for primary hyperparathyroidism--an evidence-based analysis.

Authors:  Radu Mihai; Dietmar Simon; Per Hellman
Journal:  Langenbecks Arch Surg       Date:  2009-07-10       Impact factor: 3.445

3.  Biochemical effects of calcifediol supplementation in mild, asymptomatic, hyperparathyroidism with concomitant vitamin D deficiency.

Authors:  M Luisa Isidro; Belén Ruano
Journal:  Endocrine       Date:  2009-07-14       Impact factor: 3.633

4.  Usefulness of 99mTc-SESTAMIBI Scintigraphy in Persistent Hyperparathyroidism after Kidney Transplant.

Authors:  Muheon Shin; Joon Young Choi; Sun Wook Kim; Jung Han Kim; Young Seok Cho
Journal:  Nucl Med Mol Imaging       Date:  2021-10-30

5.  Correlation between biochemical features and outcomes of preoperative imaging (SPECT-CT and Ultrasound) in primary hyperparathyroidism.

Authors:  H Anderson; K H Lim; D Simpson; S Gull; R Oprean; F Lee; C Kakos; I T Cvasciuc
Journal:  Acta Endocrinol (Buchar)       Date:  2021 Jul-Sep       Impact factor: 0.877

Review 6.  Parathyroid nuclear scan. A focused review on the technical and biological factors affecting its outcome.

Authors:  Subramanian Kannan; Mira Milas; Donald Neumann; Rikesh T Parikh; Alan Siperstein; Angelo Licata
Journal:  Clin Cases Miner Bone Metab       Date:  2014-01

7.  Comparison of Tc-99m pertechnetate images with dual-phase Tc 99m MIBI and SPECT images in primary hyperparathyroidism.

Authors:  Sait Sager; Hojjat Shafipour; Sertac Asa; Sabire Yılmaz; Serkan Teksöz; Cetin Onsel
Journal:  Indian J Endocrinol Metab       Date:  2014-07

8.  Vitamin d status in patients operated for primary hyperparathyroidism: comparison of patients from southern and northern europe.

Authors:  Erik Nordenström; Antonio Sitges-Serra; Joan J Sancho; Mark Thier; Martin Almquist
Journal:  Int J Endocrinol       Date:  2013-08-05       Impact factor: 3.257

Review 9.  A clinical perspective of parathyroid hormone related hypercalcaemia.

Authors:  Chau H Han; Christopher H Fry; Pankaj Sharma; Thang S Han
Journal:  Rev Endocr Metab Disord       Date:  2020-03       Impact factor: 6.514

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.